About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Cancer Biopsy Market Size, Forecast & Analysis by 2033
Cancer Biopsy Market

Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies , Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies), Liquid Biopsies, Others), By Applications (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55772DR
Last Updated : January 20, 2025
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Cancer Biopsy Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Kits and Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Tissue Biopsies 
          1. By Value
        3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
          1. By Value
        4. Liquid Biopsies
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast Cancer
          1. By Value
        3. Colorectal Cancer
          1. By Value
        4. Cervical Cancers
          1. By Value
        5. Lung Cancers
          1. By Value
        6. Prostate Cancers
          1. By Value
        7. Skin Cancers
          1. By Value
        8. Blood Cancers
          1. By Value
        9. Kidney Cancers
          1. By Value
        10. Liver Cancers
          1. By Value
        11. Pancreatic Cancers
          1. By Value
        12. Ovarian Cancers
          1. By Value
        13. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Kits and Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Tissue Biopsies 
          1. By Value
        3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
          1. By Value
        4. Liquid Biopsies
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast Cancer
          1. By Value
        3. Colorectal Cancer
          1. By Value
        4. Cervical Cancers
          1. By Value
        5. Lung Cancers
          1. By Value
        6. Prostate Cancers
          1. By Value
        7. Skin Cancers
          1. By Value
        8. Blood Cancers
          1. By Value
        9. Kidney Cancers
          1. By Value
        10. Liver Cancers
          1. By Value
        11. Pancreatic Cancers
          1. By Value
        12. Ovarian Cancers
          1. By Value
        13. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Kits and Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Tissue Biopsies 
          1. By Value
        3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
          1. By Value
        4. Liquid Biopsies
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast Cancer
          1. By Value
        3. Colorectal Cancer
          1. By Value
        4. Cervical Cancers
          1. By Value
        5. Lung Cancers
          1. By Value
        6. Prostate Cancers
          1. By Value
        7. Skin Cancers
          1. By Value
        8. Blood Cancers
          1. By Value
        9. Kidney Cancers
          1. By Value
        10. Liver Cancers
          1. By Value
        11. Pancreatic Cancers
          1. By Value
        12. Ovarian Cancers
          1. By Value
        13. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Kits and Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Tissue Biopsies 
          1. By Value
        3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
          1. By Value
        4. Liquid Biopsies
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast Cancer
          1. By Value
        3. Colorectal Cancer
          1. By Value
        4. Cervical Cancers
          1. By Value
        5. Lung Cancers
          1. By Value
        6. Prostate Cancers
          1. By Value
        7. Skin Cancers
          1. By Value
        8. Blood Cancers
          1. By Value
        9. Kidney Cancers
          1. By Value
        10. Liver Cancers
          1. By Value
        11. Pancreatic Cancers
          1. By Value
        12. Ovarian Cancers
          1. By Value
        13. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Kits and Consumables
        1. By Value
      4. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Tissue Biopsies 
        1. By Value
      3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
        1. By Value
      4. Liquid Biopsies
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast Cancer
        1. By Value
      3. Colorectal Cancer
        1. By Value
      4. Cervical Cancers
        1. By Value
      5. Lung Cancers
        1. By Value
      6. Prostate Cancers
        1. By Value
      7. Skin Cancers
        1. By Value
      8. Blood Cancers
        1. By Value
      9. Kidney Cancers
        1. By Value
      10. Liver Cancers
        1. By Value
      11. Pancreatic Cancers
        1. By Value
      12. Ovarian Cancers
        1. By Value
      13. Others
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Kits and Consumables
          1. By Value
        4. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Tissue Biopsies 
          1. By Value
        3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
          1. By Value
        4. Liquid Biopsies
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast Cancer
          1. By Value
        3. Colorectal Cancer
          1. By Value
        4. Cervical Cancers
          1. By Value
        5. Lung Cancers
          1. By Value
        6. Prostate Cancers
          1. By Value
        7. Skin Cancers
          1. By Value
        8. Blood Cancers
          1. By Value
        9. Kidney Cancers
          1. By Value
        10. Liver Cancers
          1. By Value
        11. Pancreatic Cancers
          1. By Value
        12. Ovarian Cancers
          1. By Value
        13. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cancer Biopsy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Qiagen N.V.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina, Inc.
    3. ANGLE Plc
    4. Myriad Genetics
    5. Hologic, Inc.
    6. Danaher
    7. F. Hoffmann-La Roche Ltd.
    8. Biocept, Inc.
    9. Lucence Diagnostics Pte. Ltd.
    10. GRAIL, Inc.
    11. Exact Sciences Corporation
    12. Thermo Fisher Scientific, Inc.
    13. Guardant Health
    14. Freenome Holdings, Inc.
    15. Biodesix (Integrated Diagnostics)
    16. Oncimmune
    17. Epigenomics AG.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global cancer biologics market size was valued at USD 114.8 billion in 2023 and is projected to reach USD 205.7 billion by 2032, registering a CAGR of 6.7% during the forecast period (2024-2032). The global cancer biologics market share is predic
Buy Now
Global Report
The global cancer biomarker market size was valued at USD 15.86 billion in 2023. It is estimated to reach USD 55.57 billion by 2032, growing at a CAGR of 14.95% during the forecast period (2024–2032). The global cancer biomarker market is prima
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.